Anti-cIAP2 antibody
5
(7 Reviews)
|
(14 Publications)
Rabbit Polyclonal cIAP2 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 14 publications.
View Alternative Names
API2, MIHC, RNF49, BIRC3, Baculoviral IAP repeat-containing protein 3, Apoptosis inhibitor 2, Cellular inhibitor of apoptosis 2, IAP homolog C, Inhibitor of apoptosis protein 1, RING finger protein 49, RING-type E3 ubiquitin transferase BIRC3, TNFR2-TRAF-signaling complex protein 1, C-IAP2, hIAP-1, hIAP1
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-cIAP2 antibody (AB23423)
ICC/IF image of ab23423 stained human HeLa cells. The cells were methanol fixed (5 min) and incubated with the antibody (ab23423, 1μg/ml) for 1h at room temperature. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Image-iTTM FX Signal Enhancer was used as the primary blocking agent, 5% BSA (in TBS-T) was used for all other blocking steps. DAPI was used to stain the cell nuclei (blue). Alexa Fluor® 594 WGA was used to label plasma membranes (red).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-cIAP2 antibody (AB23423)
ab23423 staining cIAP2 in HeLa cells treated with TMCB (ab120289), by ICC/IF. Decrease in cIAP2 expression correlates with increased concentration of TMCB, as described in literature.
The cells were incubated at 37°C for 10 minutes in media containing different concentrations of ab120289 (TMCB) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab23423 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
- FuncS
Unknown
Functional Studies - Anti-cIAP2 antibody (AB23423)
HeLa cells were incubated at 37°C for 24h with vehicle control (0 μM) and different concentrations of TMCB (ab120289). Decreased expression of cIAP2 in HeLa cells correlates with an increase in TMCB concentration, as described in literature.
Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 40μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 5% BSA before being incubated with ab23423 at 2 μg/ml and ab1801 at 2 μg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 dilution and visualised using ECL development solution.
- WB
Unknown
Western blot - Anti-cIAP2 antibody (AB23423)
A doublet was observed in Daudi, Ramos and Raji whole cell lysates (lanes 1, 4 and 5). This data suggests that ab23423 might react with both cIAP1 and cIAP2 proteins. The predicted molecular weights of cIAP1 and cIAP2 are 69-kDa and 68-kDa respectively. Abcam welcomes customer feedback and would appreciate any comments regarding this product and the data presented above.
All lanes:
Western blot - Anti-cIAP2 antibody (ab23423) at 1 µg/mL
Lane 1:
Daudi (Human Burkitt's lymphoma cell line) Whole Cell Lysate at 10 µg/mL
Lane 2:
MOLT4 (Human acute lymphoblastic leukemia cell line) Whole Cell Lysate at 10 µg/mL
Lane 3:
Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate at 10 µg/mL
Lane 4:
Ramos (Human Burkitt's lymphoma cell line) Whole Cell Lysate at 10 µg/mL
Lane 5:
Raji (Human Burkitt's lymphoma cell line) Whole Cell Lysate at 10 µg/mL
Lane 6:
HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 10 µg/mL
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-preadsorbed-ab97080'>ab97080</a>) at 1/5000 dilution
Predicted band size: 68 kDa
Observed band size: 150 kDa,35 kDa,73 kDa,75 kDa
true
Exposure time: 8min
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CIAP2 serves as a regulator in cell survival by functioning within signaling cascades. It participates in the formation of the TNF receptor complex which influences the NF-κB signaling pathway and inflammation response. By interacting with several proteins cIAP2 modulates downstream signaling effects that can influence immune responses and cellular proliferation helping cells adapt and survive stressful conditions.
Pathways
CIAP2 plays roles in both the NF-κB and the MAPK signaling pathways. Within these pathways cIAP2 interacts closely with proteins such as TRAF2 and RIP1. In the NF-κB pathway it helps in the regulation of inflammatory responses while in the MAPK pathway it contributes to cell growth and differentiation processes. These pathways highlight its function in regulating immune system responses and cell adaptability.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
EJHaem 6:e70127 PubMed40801055
2025
Applications
Unspecified application
Species
Unspecified reactive species
EMBO molecular medicine 17:645-678 PubMed39972068
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37895085
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 25:103649 PubMed35024584
2022
Applications
Unspecified application
Species
Unspecified reactive species
FEBS open bio : PubMed33484626
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 77:970-984.e7 PubMed31982308
2020
Applications
Unspecified application
Species
Unspecified reactive species
Endocrine-related cancer 27:163-174 PubMed31935194
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 19:2043-2052 PubMed32194701
2020
Applications
Unspecified application
Species
Unspecified reactive species
Experimental hematology & oncology 9:1 PubMed31908904
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 4:764-75 PubMed23972990
2013
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com